Have investors jumped the gun on the recent market surge?

The biggest question we have been asked from our members is – “when is the best time to take advantage on the stock market?” Now, with so many opinions and a vast range of historical data, I will break down the situation into 400 words or less. Now our role at YIG is not to […]

Hoth Therapeutics gaining ground in the race for a COVID-19 vaccine

In recent weeks, Biotech companies across the globe have been collaborating together to produce a COVID-19 vaccine for global production and distribution. The reward for such an accomplishment would add prestige and intrinsic value at a scale we have never witnessed. The vaccine will save millions of lives in the years to follow, as well as […]

Here’s why PAR is worth watching now more than ever?

When thinking of a biotech market mover Paradigm Biopharmaceuticals (ASX: PAR) instantly comes to mind. Paradigm, through its repurposed drug Zilosul, aims to alleviate the suffering and cartilage degradation of Osteoarthritis. PAR’s impressive clinical developments in osteoarthritis and 240% surge in 2019 captivated both the scientific and investment world. Paradigm kickstarted 2020 off with a […]